These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2866563)

  • 41. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M; Tsalikian E; Bohannon NV; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of plasma HVA and treatment response in a large series of patients with schizophrenia.
    Davila R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():519A-520A. PubMed ID: 1354057
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
    Kendler KS; Heninger GR; Roth RH
    Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
    Mueller GP; Simpkins J; Meites J; Moore KE
    Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 46. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 47. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjects.
    Kahn RS; Knott P; Gabriel S; DuMont K; Mastroianni L; Davidson M
    Biol Psychiatry; 1992 Dec; 32(11):1055-61. PubMed ID: 1467386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postsynaptic supersensitivity in schizophrenia.
    Pandey GN; Garver DL; Tamminga C; Ericksen S; Ali SI; Davis JM
    Am J Psychiatry; 1977 May; 134(5):518-22. PubMed ID: 848578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE; Owen RR; Litman RE; Pickar D
    Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    Ben-Shachar D; Pinhassi B; Youdim MB
    Eur J Pharmacol; 1991 Sep; 202(2):177-83. PubMed ID: 1687031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sublingual apomorphine as a neuroendocrine probe.
    Brunerova L; Potockova J; Horacek J; Koprivova H; Rehula M; Andel M
    Psychiatry Res; 2012 Jul; 198(2):297-9. PubMed ID: 22394588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.
    Deutsch SI; Halperin R; Stanley M; Davis KL
    Neurochem Res; 1985 Apr; 10(4):491-8. PubMed ID: 2582289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration.
    Lupien S; Richter R; Risch SC; Mirow A; Gillin JC; Hauger RL
    Psychiatry Res; 1995 Sep; 58(1):23-35. PubMed ID: 8539309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z; Davidson M; Jaff S; McQueeney R
    Schizophr Res; 1991; 5(1):81-3. PubMed ID: 1677266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of apomorphine hydrochloride administration on serum concentrations of prolactin and growth hormone in cattle.
    Gorewit RC
    Experientia; 1981 Feb; 37(2):204-6. PubMed ID: 7238762
    [No Abstract]   [Full Text] [Related]  

  • 58. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
    Rupniak N; Hong M; Mansfield S; Fleminger S; Dyer R; Jenner P; Marsden CD
    Eur J Pharmacol; 1983 Sep; 93(3-4):195-200. PubMed ID: 6139285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.
    Valchár M; Metysová J; Chlebounová J; Dlabac A
    Psychopharmacology (Berl); 1982; 76(4):381-4. PubMed ID: 6126896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.